Multi-Scale In Vivo Systems Analysis Reveals the Influence of Immune Cells on TNF-α-Induced Apoptosis in the Intestinal Epithelium by Lau, Ken Siu-Kwong et al.
Multi-Scale In Vivo Systems Analysis Reveals the
Influence of Immune Cells on TNF-a-Induced Apoptosis
in the Intestinal Epithelium
Ken S. Lau1,2,3,4,5,6, Virna Cortez-Retamozo3, Sarah R. Philips1,2,3, Mikael J. Pittet3,
Douglas A. Lauffenburger5,6, Kevin M. Haigis1,2,3,4*
1Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, 2Center for Cancer Research, Massachusetts General
Hospital, Charlestown, Massachusetts, United States of America, 3Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of
America, 4Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America, 5Department of Biological Engineering, Massachusetts
Institute of Technology, Cambridge, Massachusetts, United States of America, 6 Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology,
Cambridge, Massachusetts, United States of America
Abstract
Intestinal epithelial cells exist within a complex environment that affects how they interpret and respond to stimuli. We
have applied a multi-scale in vivo systems approach to understand how intestinal immune cells communicate with
epithelial cells to regulate responses to inflammatory signals. Multivariate modeling analysis of a large dataset composed of
phospho-signals, cytokines, and immune cell populations within the intestine revealed an intimate relationship between
immune cells and the epithelial response to TNF-a. Ablation of lymphocytes in the intestine prompted a decrease in the
expression of MCP-1, which in turn increased the steady state number of intestinal plasmacytoid dendritic cells (pDCs). This
change in the immune compartment affected the intestinal cytokine milieu and subsequent epithelial cell signaling
network, with cells becoming hypersensitive to TNF-a-induced apoptosis in a way that could be predicted by mathematical
modeling. In summary, we have uncovered a novel cellular network that regulates the response of intestinal epithelial cells
to inflammatory stimuli in an in vivo setting.
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Introduction
Tumor necrosis factor alpha (TNF-a) is a pro-inflammatory
cytokine that operates through a pleiotropic signaling network to
influence a diverse array of cellular behaviors, including the
induction of apoptosis, survival, proliferation, cell cycle arrest, or
differentiation [1]. TNF-a primarily signals through the ubiqui-
tously expressed receptor TNFR1, with TNFR2 playing an
accessory role. Upon binding to ligand, the death domain of
TNFR1 recruits TRADD, RIP1, TRAF2/5, and cIAP1/2, which
together constitute complex I at the cell surface [2]. Complex I is
thought to primarily play a pro-survival role by activating
downstream NFkB and MAPK pathways [3]. Upon internaliza-
tion of this complex, cIAP1/2 auto-degradation triggers the
release of RIP, which forms complex 2 with FADD and pro-
caspase 8 [4]. In conjunction with the down-regulation of c-Flip,
complex 2 activates downstream caspase pathways to trigger
apoptosis. Although the membrane proximal components of TNF-
a signaling are relatively well defined, the downstream mecha-
nisms for triggering cellular behaviors depend on the wiring of the
signaling network, which is strongly dependent upon cellular
context. Because TNF-a activates a combinatorial complement of
pathways that overlaps with those activated by other factors in the
cellular environment, and because different cell types exhibit
distinct responses to TNF-a, it is a challenge to decipher how
TNF-a controls phenotypic outcomes in a physiological setting.
Dysregulation of TNF-a signaling contributes to several distinct
chronic inflammatory conditions in the gut, such as inflammatory
bowel disease, celiac disease, and peptic ulcer disease [5–7]. These
conditions are characterized by alterations in intestinal homeo-
stasis, which depends upon regulated interaction between the
immune system, the intestinal epithelium, and the commensal
flora residing in the intestinal lumen. Under homeostatic
conditions, the unilaminar epithelium provides a barrier between
the commensal flora and the immune system. As such, the
epithelium is an active player, along with macrophages, dendritic
cells, and neutrophils, in innate immunity within the intestine.
When the barrier is intact, regulatory T (Treg) cells suppress
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adaptive immune responses. Loss of barrier function leads to
activation of the adaptive immune component of the gut, resulting
in inflammation. Different subtypes of T helper (Th) cells are
activated in different types of chronic intestinal inflammation. For
example, Th1/Th17 responses drive Crohn’s disease, while Th2-
like responses drive ulcerative colitis [8]. Recent studies have
shown that inflammatory cytokines, such as those that define Th
subsets, can also be produced by innate immune cells in the gut.
Th17-like responses can arise from innate lymphoid cells (ILCs)
[9–11] and Th-2-like responses from natural killer (NK) cells
[12,13].
Under both homeostatic and pathologic conditions, the activity
of the innate and adaptive components of the intestine can
strongly influence the behavior of the intestinal epithelium and
vice versa. For example, T cell receptor (TCR)-cd+ lymphocytes
regulate the proliferation and differentiation of epithelial cells
through extracellular factors such as keratinocyte growth factor-1
[13,14]. T cells also direct the differentiation of epithelial cells by
regulating Notch signaling, an important pathway in specifying the
goblet cell lineage, which generates the mucus barrier [15].
Reciprocally, goblet cells can deliver antigens to dendritic cells to
trigger T cell responses [16]. The heterologous cellular interac-
tions that occur within the intestinal microenvironment create a
situation where epithelial cells must receive and integrate mixtures
of signals to dictate behaviors. The epithelial response to TNF-a
takes place within this complex milieu, but the exact manner in
which the environmental context modulates the integration of
inflammatory signals to alter TNF-a-induced phenotypes in the
intact tissue is not well understood.
Applying a systems biology perspective to explore communica-
tion mechanisms within the complex intestinal microenvironment
will undoubtedly lead to novel insights into TNF-a biology,
inflammatory diseases, and, more generally, heterologous cell
interactions that occur as part of biological phenomena in complex
tissues. Previously, we have demonstrated that the complex
signaling effects elicited by TNF-a in the intestinal epithelium
can be mathematically integrated into a signaling network state to
predict epithelial cell behavior [17]. Here, we demonstrate that
intestinal immune cells play a critical role in regulating the
response of the epithelium to TNF-a. The effect is mediated by the
pro-survival activity of MCP-1 and the pro-death activity of IFN-
c, two cytokines that, like TNF-a, exert pleiotropic effects on many
cell types.
Results
Loss of Intestinal Lymphocytes, But Not the Commensal
Flora, Alters the Epithelial Response to TNF-a
We have previously used systems biology to characterize how
cell intrinsic signaling regulates the response of the intestinal
epithelium to TNF-a [17]. Because homeostasis within the
epithelium is affected by components of the intestinal microenvi-
ronment, we hypothesized that non-cell-autonomous signaling
might also play a significant role in the epithelial response to TNF-
a (Figure 1A). To test how one component of the intestinal
microenvironment—the immune component—might regulate the
epithelial response to TNF-a, we compared responses of wild-type
(WT) and recombinase-activating gene 1 (Rag1) knockout mice,
which lack adaptive lymphocytes, to acute TNF-a exposure. We
intravenously administered TNF-a (5 mg) to isogenic WT and
Rag1 null animals and, over a time course of 4 h, measured the
onset of apoptosis in the intestinal epithelium (Figure 1B). The
duodena of Rag1 null mice displayed a qualitatively enhanced
apoptotic response to TNF-a when compared to WT (Figure 1C).
Consistent with our previous observations [17], exogenous TNF-a
did not trigger apoptosis in the ilea of WT or Rag1 mutant animals
(unpublished data). Careful quantification by Western blotting for
cleaved caspase 3 (CC3, Figure S1A) revealed that the apoptotic
response in Rag1 null mice differed from WT both in timing and
in magnitude. TNF-a-induced apoptosis occurred earlier in Rag1
null mice than in WT and with increased magnitude (Figure 1D).
These results demonstrate that the immune component of the
intestine is critical for modulating the epithelial response to TNF-a
in a non-cell-autonomous manner.
Mutation of Rag1 affects the development of both B and T cells.
To determine whether loss of either of these types of lymphocytes
is specifically responsible for the enhanced apoptotic response of
the intestinal epithelium, we acutely treated animals that lacked
either T cells or B cells with TNF-a. Interestingly, T cell receptor
beta/delta (Tcrb/Tcrd) double null animals, which lack T cells,
and Immunoglobulin heavy chain mu (Ighm) null animals, which
lack B cells, both exhibited an enhanced apoptotic response to
TNF-a relative to WT controls (Figure S1B), suggesting that both
of the major immune cell types in the gut are required for
dampening the epithelial TNF-a response.
While WT and Rag1 null mice differ in the presence of resident
T cells within the intestinal lamina propria, we noted that acute
treatment of WT mice with TNF-a also led to recruitment of
additional T cells to the intestine (Figure S1C). To determine
whether these recruited T cells are required to suppress TNF-a-
induced epithelial apoptosis, we blocked their recruitment to the
intestinal lamina propria from the mesenteric lymph nodes by pre-
treating WT mice with a neutralizing antibody for mucosal
addressin cell adhesion molecule-1 (MAdCAM-1), the endothelial
ligand in the intestine for homing a4b7 integrins on T cells
[18,19]. Blocking MadCAM-1 abolished the recruitment of T cells
to the lamina propria by TNF-a, but, as expected, did not
significantly affect the presence of resident T cells (Figure S1C).
Moreover, this perturbation did not alter TNF-a-induced apop-
tosis in intestinal epithelial cells (Figure S1D), indicating that
recruited T lymphocytes are not likely to be important for
modulating the epithelial apoptotic response.
The commensal flora constitutes another feature of the
intestinal microenvironment that plays an important role in
Author Summary
Homeostasis in the intestine is maintained through
regulated interaction between several cell communities:
the intestinal epithelium, intestinal immune cells, and the
commensal flora living in the gut. A breakdown in the
communication network that exists between these three
components can lead to a pathologic state, for example
inflammation. We have used computational modeling of
intracellular and extracellular signaling pathways to deter-
mine how intestinal immune cells control the response of
intestinal epithelial cells to the inflammatory cytokine
tumor necrosis factor alpha (TNF-a). Cycles of computa-
tional modeling and experimental perturbation revealed a
network in which epithelial cells communicate with the
intestinal immune component via monocyte chemo-
attractant protein 1 (MCP-1) and the immune cells signal
back to the epithelium through interferon gamma (IFN-c).
This extracellular signaling pathway modulates the epi-
thelial apoptotic response to TNF-a in order to regain a
state of homeostasis. Our study highlights the power of
applying systems biology approaches to mouse models in
order to characterize complex biological phenomena.
In Vivo Systems Analysis of TNF-Induced Apoptosis
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regulating epithelial homeostasis. As such, we sought to determine
whether acute elimination of the endogenous microbiota would
affect the response of the intestinal epithelium to TNF-a.
Treatment of WT mice with broad-spectrum antibiotics eliminat-
ed the commensal flora population that could be cultured from
fecal pellets (Figure S2A), but did not significantly affect TNF-a-
induced apoptosis of intestinal epithelial cells (Figure S2B).
Altogether, these results suggest that resident lymphocytes, but
not the endogenous microbiota, play a major role in the short-
term response of the intestinal epithelium to TNF-a-induced
epithelial damage. It remains unclear, however, whether long-term
depletion of gut microbes or antibiotic-resistant microbiota may
play a role in the acute response to TNF-a.
Mathematical Modeling Identifies an Epithelial Signaling
Network That Distinguishes Apoptotic Phenotypes
To identify the mechanisms by which immune cells modulate
the magnitude of TNF-a-induced apoptosis in epithelial cells, we
first asked whether network-level signaling responses to TNF-a
varied in the different genetic backgrounds. To sample the
network state, we collected a time course dataset across central
signaling pathways (Figure S3) from intestinal lysates using Bio-
Plex signaling assays under various conditions: (i) late, low-
magnitude apoptosis in the duodena of WT mice treated with 5 mg
of TNF-a; (ii) early, low-magnitude apoptosis in the duodena of
WT mice treated with 10 mg of TNF-a; (iii) early, high-magnitude
apoptosis in the duodena of Rag1 null mice treated with 5 mg of
TNF-a; and (iv) no apoptosis in the ilea of all animals, regardless of
genotype or treatment (Figure 2A). Altogether, we collected 2,160
data points (45 animals, 2 sections per animal, 12 signals per
sample, 2 technical duplicates) for this initial model-generating
experiment. In addition to the expected biological variation
observed between animals, we observed strong condition-induced
variation (Figure S4). We then used our signaling dataset to
construct a PLSDA model that accounts for the large increase in
the magnitude of apoptosis seen in Rag1 null animals (Figure 2B).
Figure 1. Loss of intestinal lymphocytes affects TNF-a-induced cell death in the intestinal epithelium. (A) Schematic representation of
our driving hypothesis. Intestinal epithelial homeostasis is regulated by signals from the intestinal microenvironment. By extension, we hypothesized
that perturbation of the commensal flora or components of the intestinal immune system (dendritic cells, B cell, T cells, macrophages) will affect how
the epithelium responds to acute challenge with TNF-a. (B) Schematic of the experimental design. Wild-type or Rag1 null animals were exposed to
TNF-a (5 or 10 mg in PBS) by intravenous injection. Mice were sacrificed at specific time points to compile a time course of TNF-a action. Protein
lysates were derived from the duodena and ilea and then subjected to various analyses in order to collect datasets for mathematical modeling.
Hypotheses based on computational models were tested by making perturbations and then the model was refined. (C) Immunohistochemistry for
cleaved caspase 3 (CC3) in the duodena of untreated and treated animals. TNF-a-induced apoptosis occurs much more frequently in Rag1 null
animals than in wild-type. (D) Quantification of caspase 3 cleavage by quantitative Western blotting, demonstrating the effect of Rag1 mutation on
the timing and magnitude of TNF-a-induced apoptosis. CC3 data are normalized to vehicle-treated control and plotted on a log2 scale. Error bars
represent the SEM for three mice.
doi:10.1371/journal.pbio.1001393.g001
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We selected a three-dimensional model based on the lowest
classification error of calibration coupled to the lowest classifica-
tion error of validation of the three duodenal classes (Figure S5A–
C). The distinction between ileal samples by the model was
suboptimal (Figure S5C), which was expected due to the similarity
in phenotype (i.e., no apoptosis) and signaling of ileal samples
under all conditions. It can be appreciated that the high-
magnitude apoptotic phenotype is not just an extension of the
early timing phenotype, but is in fact a clearly separate class, since
these two phenotypic classes (timing and magnitude) lie on
different axes (Figure 2B). Consequently, different mechanisms of
signaling classify duodenal phenotypes based on timing or
magnitude. Late activation of Erk, Mek, Rsk, p38, S6, and IkBa
separates apoptotic phenotypes by timing (early from late), similar
to our previous study (Figure S5D) [17]. By contrast, early
signaling through Rsk, Mek, Akt, and IkBa distinguishes the
apoptotic phenotypes by magnitude (Figure 2C). These observa-
tions indicate that magnitude and timing of apoptosis within the
intestinal epithelium are controlled by distinct ‘‘axes’’ of signaling,
suggesting that TNF-a-induced apoptosis is dysregulated in
multiple ways in animals lacking adaptive lymphocytes.
Computational Modeling of Cytokine Signaling Reveals a
Non-Cell-Autonomous Network Controlling Apoptosis in
the Intestinal Epithelium
The observation that lymphocyte perturbation resulted in
altered epithelial signaling and TNF-a response prompted us to
investigate whether immune cells communicate with epithelial
cells through cytokine networks. To examine whether cytokine
expression is disrupted at a network level, we measured a panel of
inflammatory cytokines in the intestine after TNF-a stimulation
(4,140 data points—45 animals, 2 sections per animal, 23 signals
per sample, 2 technical duplicates) (Figure 3A). The cytokine
Figure 2. The epithelial TNF-a signaling network is altered by the absence of lymphocytes. (A) Measurement of protein phosphorylation
in intestinal tissue lysates by Bio-Plex. The heat map is organized such that the columns represent the phospho-signal time courses, while the rows
represent the experimental conditions. Different doses, regions, and genotypes are color-coded. Each phospho-signal is arranged sequentially as a
function of time (left to right, 0 to 4 h). The intensity of the heat map represents the average of technical duplicates of the median fluorescence
intensity (normalized to the highest value of each signal) resulting from each assay. Data are compiled from three independent experiments for each
condition. (B) A three-dimensional PLSDA model constructed using signaling time courses obtained from the different conditions and their
correlating apoptotic phenotypes. Each data point represents scores generated by the model, composed of all signaling time courses of a particular
experimental condition mapped onto the three-dimensional latent variable space. The three orthogonal latent variable axes separate the scores by
apoptotic phenotype: LV1 by the presence or absence of apoptosis, LV2 by the magnitude of apoptosis, and LV3 by the timing of apoptosis. The
percentages on the axes represent the percent variance in the dataset captured by a particular LV. (C) Loadings on LV2, the latent variable that
correlates the magnitude of TNF-a-induced apoptosis. The y-axis quantifies the positive or negative contribution of a particular signal to LV2.
doi:10.1371/journal.pbio.1001393.g002
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dataset contained a similar degree of variation as did the phospho-
protein signaling dataset (Figure S6). We surmised that, with
respect to modulation of TNF-a-induced apoptosis, the cytokine
network lies upstream of the epithelial signaling network, and thus,
late apoptosis can only be modulated by early alterations in
cytokines. To identify cytokines that are important in modulating
the apoptotic phenotype, we constructed a two-dimensional
PLSDA model separating the three phenotypic classes (late/low
apoptosis, early/low apoptosis, and early/high apoptosis) by early
cytokine expression within the duodenum (Figure 3B). A variety of
inflammatory cytokines were positively correlated with the high
magnitude of TNF-a-induced apoptosis in Rag1 null duodenum,
but only one, MCP-1 (monocyte chemotactic protein 1), correlated
with the late and low magnitude of apoptosis in WT duodenum
(Figure 3C), suggesting that MCP-1 is protective against TNF-a-
induced apoptosis in the intestinal epithelium.
MCP-1 Protects the Intestinal Epithelium from TNF-a-
Induced Apoptosis
To test directly whether it singularly regulates the epithelial
apoptotic response to TNF-a, we functionally neutralized MCP-1
in WT animals with anti-MCP-1 antibody prior to TNF-a
administration. Next, we collected a signaling dataset representing
a time course of TNF-a stimulation (5 mg) coincident with MCP-1
neutralization (360 data points—15 mice, 12 signals, 2 technical
duplicates). Application of this signaling dataset to the original
three-dimensional PLSDA model of signaling (Figure 2B) demon-
strated that MCP-1 neutralization shifted the signaling data from
the late/low apoptosis class (WT duodenum, 5 mg TNF-a) towards
the early/high-magnitude apoptosis class (Rag1 null duodenum)
(Figure 4A). Classification analysis revealed that the anti-MCP-1
signaling dataset classified solely into the high-magnitude apoptosis
class (Figure 4B), but not into other classes (Figure S7). By contrast,
the signaling data obtained from control WT mice pretreated with
non-specific antibody (rat IgG) classified into the low-magnitude
and late apoptosis classes, but not into the high-magnitude class
(Figures 4B, S7). Our PLSDA model indicated that acute
neutralization of MCP-1 primes the signaling network of intestinal
epithelial cells from WT mice to respond to TNF-a in a similar
manner as epithelial cells from Rag1 null mice. Consequently, we
predicted that neutralization of MCP-1 in WT mice would lead to
early and high-magnitude apoptosis after treatment with TNF-a.
Figure 3. The cytokine milieu is modulated by the presence or absence of lymphocytes. (A) Measurement of cytokine protein levels in
intestinal tissue lysates by Bio-Plex. The heat map is organized in a similar manner as Figure 2A. Data are compiled from three independent
experiments for each condition. (B) A two-dimensional PLSDA model constructed using early cytokine data (0, 0.5, 1 h) obtained from the different
conditions and their correlating apoptotic phenotypes. Each data point represents scores generated by the model, composed of the early time points
of all cytokines measured of a particular experimental condition mapped onto the two-dimensional latent variable space. The dotted gray line
represents the 95% confidence limit of the distribution of the scores. The two orthogonal latent variable axes separate the scores by apoptotic
phenotype: LV1 by the magnitude of apoptosis and LV2 by the timing of apoptosis. The percentages on the axes represent the percent variance in
the dataset captured by a particular LV. (C) Loadings for the PLSDA model plotted on LV1 and LV2. MCP-1 clusters most significantly with the lowest
degree of apoptotic phenotype (low magnitude, late timing).
doi:10.1371/journal.pbio.1001393.g003
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In order to validate this model-derived hypothesis, we measured
TNF-a-induced apoptosis in the duodenum of WT mice
pretreated with anti-MCP-1. Compared to mice pretreated with
non-specific antibody, intestinal epithelial cells from mice treated
with anti-MCP-1 underwent earlier and higher magnitude
apoptosis (Figure 4C). These observations suggest that MCP-1
strongly attenuates TNF-a-induced apoptosis in the intestinal
epithelium by causing systems-level shifts within the epithelial
signaling network.
MCP-1 Is Expressed by Secretory Epithelial Cells
MCP-1, like TNF-a, is a pleiotropic cytokine that can affect a
diverse array of cell types in a variety of ways. As such, it was
unclear exactly how MCP-1 was functioning within the intestine to
regulate the epithelial response to TNF-a. We set out to test
multiple hypotheses relating to the relationship between MCP-1
and TNF-a-induced epithelial apoptosis. Based on an abundance
of published work, our initial hypothesis was that lymphocytes
secrete MCP-1 to recruit macrophages to the lamina propria and
that this protects against TNF-a-induced epithelial apoptosis.
Based on this hypothesis, we predicted that MCP-1 expression in
the intestine would be detectable in intravillus lymphocytes.
Surprisingly, we found that immunohistochemistry (IHC) for
MCP-1 detected expression primarily in secretory intestinal
epithelial cells, namely in goblet cells in the villi and Paneth cells
at the base of the crypt (Figure 5A). This observation was
consistent with epithelial cells being the primary source of MCP-1
in the intestine, but it did not rule out the possibility that
lymphocytes express high levels of MCP-1 following stimulation
with TNF-a. To address this issue, we isolated epithelial and
immune cells from WT intestine before and after TNF-a
treatment and performed real-time PCR (RT-PCR) for MCP-1.
Among the immune cell types analyzed, we found that T cells, but
not B cells or macrophages, expressed MCP-1 and that its
expression was stimulated 4–5-fold by TNF-a (Figure 5B).
Epithelial cells also expressed low levels of MCP-1 prior to
exposure to TNF-a, but its expression was stimulated 2,000-fold
by TNF-a (Figure 5B). This stimulation of expression is likely to be
a significant underestimate of MCP-1 expression by secretory cells,
as they comprise only about 10% of the epithelial cell population
in the duodenum.
While these IHC and RT-PCR studies support the hypothesis
that MCP-1 detected in the intestine is primarily derived from
epithelial cells, a more direct way to link MCP-1 to secretory cells
is to modify the number of those cells within the epithelium.
Treatment of mice with dibenzazepine (DBZ), an inhibitor of c-
secretase, has been shown to increase the number of secretory
epithelial cells in the intestinal epithelium [20]. We found that
DBZ treatment increased the number of secretory epithelial cells
Figure 4. Neutralization of MCP-1 affects epithelial signaling
and TNF-a-induced apoptosis in the intestine. (A) Effect of MCP-1
neutralization on TNF-a-induced signaling. Phospho-signaling data
from the duodena of wild-type mice pre-treated with MCP-1
neutralizing antibody (magenta) were mapped onto the three-
dimensional LV space to visually demonstrate the classification of
these data with the original Rag1 null dataset. (B) Numerical
classification of the wild-type anti-MCP1 signaling dataset into the
Rag1 null class. The y-axis shows the numerical result calculated with
the PLSDA function of classification into the ‘‘high apoptosis’’
phenotypic class (class 3). The broken red line is the threshold defining
classification. Signaling data from the duodenal tissues of control mice
pretreated with non-specific antibody (cyan) do not surpass the
threshold for classification into this class. (C) Experimental results
validating model predictions. Time course of caspase 3 cleavage
induced by TNF-a, as determined by quantitative Western blotting after
pretreatment with MCP-1 neutralizing antibody (magenta) or non-
specific antibody (cyan). CC3 data are normalized to vehicle-treated
control and plotted on a log2 scale. Error bars represent the SEM for
three mice.
doi:10.1371/journal.pbio.1001393.g004
In Vivo Systems Analysis of TNF-Induced Apoptosis
PLOS Biology | www.plosbiology.org 6 September 2012 | Volume 10 | Issue 9 | e1001393
and, at the same time, decreased the number of lymphocytes in the
intestine (Figure 5C,D). The expression of MCP-1 was positively
correlated with the number of secretory epithelial cells, with higher
expression in animals treated with DBZ (Figure 5E). By contrast,
most of the other cytokines that we measured in this experiment
positively correlated with the number of lymphocytes, with lower
expression in animals treated with DBZ (Figure 5E). Altogether,
these studies are consistent with secretory epithelial cells providing
the MCP-1 that protects the intestinal epithelium from TNF-a-
induced apoptosis.
MCP-1 Regulates Plasmacytoid Dendritic Cell Migration
to the Intestine
While our data suggested that MCP-1 comes from epithelial
cells, the mechanism of action of MCP-1 remained a question.
Published studies have shown that this cytokine can act directly on
epithelial cells, which also express the MCP-1 receptor, CCR2
[21]. Autocrine feedback loops have also been shown to protect
intestinal epithelial cells from TNF-a-induced apoptosis using in
vitro systems [22]. Based on these observations, we explored the
hypothesis that MCP-1 functions in an autocrine manner to
protect the epithelium against TNF-a-induced apoptosis. The
major prediction of this hypothesis is that exogenous MCP-1 will
protect the duodena of Rag1 null animals from TNF-a-induced
apoptosis. Nevertheless, intravenous injection of Rag1 null animals
with MCP-1 prior to TNF-a treatment failed to inhibit apoptosis,
even though the tissue levels of MCP-1 were returned to that of
WT (Figure S8A,B).
MCP-1 is mainly known as a chemo-attractant that recruits
monocytes, macrophages, dendritic cells, and T cells to sites of
Figure 5. MCP-1 is expressed by secretory epithelial cells. (A) Expression of MCP-1 in the duodenum of wild-type, Rag1 null, and Mcp1 null
mice as demonstrated by immunohistochemistry. The MCP-1-positive cells are goblet and Paneth cells. (B) Expression of MCP-1 in sorted cells. MCP-1
could not be detected in sorted B cells or macrophages. T cells express relatively low levels of MCP-1 in the basal state and induce MCP-1 5-fold after
exposure to TNF-a. Epithelial cells also express relatively low levels of MCP-1 in the basal state and induce MCP-1 2,000-fold after exposure to TNF-a.
(C) Increase in goblet cell number after treatment with DBZ. Intestinal tissue sections were stained with Alcian blue to highlight goblet cells. (D)
Decrease in intestinal lymphocytes after treatment with DBZ. Immune cell types were quantified by FACS. (E) Expression of cytokines after treatment
with DBZ. MCP-1 expression is increased in the intestines of animals treated with DBZ. Expression of IL-1b, IL-6, and MIP-1b decreased in animals
treated with DBZ.
doi:10.1371/journal.pbio.1001393.g005
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inflammation. We next tested the hypothesis that epithelial cells
secrete MCP-1 to recruit a protective immune cell type (possibly
macrophages) to the intestine. Nevertheless, by performing FACS
analysis on immune cell populations from the gut, we found no
evidence that Rag1 null animals or WT animals treated with anti-
MCP-1 had fewer intestinal macrophages than control WT
animals (Figure 6A).
All of our initial hypotheses relating to the function of MCP-1
were developed under the assumption that WT animals are
actively resistant to TNF-a-induced apoptosis. Because our
experimental results failed to support these hypotheses, we
explored the possibility that Rag1 null mice are actively sensitive
to TNF-a-induced apoptosis. We tested the hypothesis that the low
levels of MCP-1 in Rag1 null intestines led to an increased number
of deleterious immune cells relative to WT animals. Indeed, we
identified three distinct immune populations that were over-
represented in Rag1 null intestines: CD11b- macrophages, natural
killer (NK) cells, and plasmacytoid dendritic cells (pDCs)
(Figure 6A). To determine the functional significance of these
specific cell types, we ablated them in Rag1 null animals (Figure
S8C,D). Ablation of macrophages and NK cells had no significant
effect on TNF-a-induced apoptosis in Rag1 null mice, but
depletion of pDCs was strongly protective (Figure 6B). Consistent
with the notion that pDCs potentiate TNF-a-induced apoptosis,
treatment of WT mice with anti-MCP-1 led to an increase of
intestinal pDCs coincident with increased TNF-a-induced apop-
tosis (Figure 6A).
pDCs Regulate the Epithelial Signaling Network by
Increasing Tissue Levels of IFN-c
Our data implicate pDCs in actively sensitizing the intestinal
epithelium to TNF-a-induced apoptosis. We next investigated
whether the increased or decreased presence of pDCs is sensed
through the epithelial signaling network to change the magnitude
of TNF-a-induced apoptosis. Our original modeling analysis
comparing WT and Rag1 null animals identified four early
signals (0.5 h post-TNF-a) that combinatorially contribute to the
magnitude of TNF-a-induced apoptosis: p-Rsk, p-Mek, p-IkBa,
Figure 6. MCP-1 regulates the presence of plasmacytoid dendritic cells in the intestine. (A) Quantification of basal immune cell numbers
by FACS. Data are normalized to the number of cells in the duodena of wild-type mice. Error bars represent the SEM for six animals. N.D., not
detected. (B) Quantification of caspase 3 cleavage in the duodena of Rag1 null animals in which specific immune cell populations have been
depleted. Data are normalized to Rag1 null control mice and error bars represent the SEM for three animals. (C) The projection of different
perturbation conditions (wild-type, wild-type+anti-MCP-1, Rag1 null, and Rag1 null+anti-PDCA1) along LV2 based on p-Mek, p-IkBa, p-Rsk, and p-Akt
were measured at 0.5 h post-TNF-a treatment. These phospho-signals were identified as the primary loadings for LV2, which classifies the apoptotic
phenotype by magnitude, of the PLSDA model of epithelial phospho-signaling.
doi:10.1371/journal.pbio.1001393.g006
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and p-Akt (Figure 2C). We measured these four signals after
perturbations that increase (anti-MCP-1 in WT mice) or decrease
(anti-PDCA-1 in Rag1 null mice) pDCs and examined how the
signals from these conditions project onto LV2 (which separates
low- and high-magnitude apoptosis) of the PLSDA model based
on the four signals. Increasing intestinal pDCs in WT mice
reversed the direction of projection by these signals onto LV2,
signifying that the behavior of the epithelial signaling network is
modified in such a way that gives rise to increased apoptosis
(Figures 6C, S9). Alternately, decreasing pDCs in Rag1 null mice
reversed the projection, consistent with the experimental obser-
vation that ablation of pDCs decreased the magnitude of TNF-a-
induced apoptosis in these mice (Figures 6C, S9). Based on these
studies, we conclude that changes in the composition of intestinal
immune cell populations remodel the signaling network in
epithelial cells, ultimately leading to an altered response to
TNF-a.
The major question that remained was: How does the change in
the number of pDCs affect the epithelial signaling network? We
posited that pDCs might communicate with epithelial cells,
directly or indirectly, using cytokines. Based on our original
PLSDA model, we identified MCP-1 as being protective because it
correlated with late/low apoptosis (Figure 3C). We speculated that
a similar analysis might allow us to identify cytokines that
correlated with early/high apoptosis (i.e., those that might be
functioning downstream of pDCs). Nevertheless, the right side of
the model, which correlates to high-magnitude apoptosis, is
obscured by the multitude of signals present (Figure 3C). This
result could arise from one of two scenarios: (1) many signals
combinatorially contribute to high-magnitude apoptosis, or (2)
many of the signals are just correlative and not causative, due to
the lack of a sufficient number of perturbations to constrain the
model. To gain a better perspective of the cytokines that modulate
the magnitude of apoptosis, we augmented our model with early
cytokine data from our four distinct experimental conditions (WT,
WT treated with anti-MCP-1, Rag1 null, and Rag1 null treated
with anti-PDCA-1) (Figure S10). The resulting modified PLSDA
model identified high interferon gamma (IFN-c) levels as
correlating with a high magnitude of TNF-a-induced apoptosis
(Figure 7A).
To test whether IFN-c plays a mechanistic role in the
potentiation of TNF-a-induced apoptosis by pDCs, we first
treated WT animals with exogenous IFN-c concurrent with
TNF-a. We found that a single injection of IFN-c was sufficient to
enhance TNF-a-induced apoptosis in the WT intestinal epitheli-
um (Figure 7B). Consistent with this observation, neutralization of
IFN-c in Rag1 null animals was strongly protective (Figure 7B).
Similar to neutralization of MCP-1, treatment with ectopic IFN-c
reversed the direction of signal projection onto LV2 of our PLSDA
model, suggesting that it influences the epithelial signaling network
downstream of pDCs (Figure 7C).
Discussion
Tissue homeostasis is maintained by a complex biological
network consisting of cell intrinsic and extrinsic factors. Data-
driven computational modeling provides a powerful framework for
understanding how complex networks are established and
maintained in a heterogeneous system [23]. The mammalian
intestine is a prime example of a complex, heterogeneous system in
which homeostasis is controlled by interactions between the
intestinal epithelium, the flora residing within the gut lumen, and
the immune system residing in the lamina propria. To begin to
understand how signaling within this complex system is regulated
to maintain homeostatic balance, we applied a top-down approach
to identify, and then disrupt, components within the system that
modulate cell death in response to the proximal inflammatory
stimulus tumor necrosis factor alpha (TNF-a). We initially
observed that Rag1 mutant animals exhibited a strongly enhanced
apoptotic response to TNF-a relative to WT controls
(Figure 1C,D). To understand the mechanisms underlying the
phenotypic difference between WT and Rag1 null animals, we
employed an in vivo systems biology approach that integrated
immunological, cytokine, phospho-protein signaling, and pheno-
typic data. Our results demonstrated a critical link between
plasmacytoid dendritic cells (pDCs) and the intestinal epithelial cell
signaling network in modulating TNF-a-induced apoptosis, and
Figure 7. IFN-c regulates TNF-a signaling and apoptosis in a pDC-dependent manner. (A) A two-dimensional PLSDA model constructed
using early cytokine data from four different experimental conditions (wild-type+IgG, wild-type+anti-MCP-1, Rag1 null+IgG, Rag1 null+anti-PDCA-1) in
duodenal lysates. The loadings plot for this four-condition PLSDA model identifies IFN-c as correlating with high-magnitude apoptosis. (B) Caspase 3
cleavage induced 2 h post-TNF-a administration in the duodena of wild-type mice co-treated with PBS (cyan) or IFN-c (purple) and Rag1 null mice
pretreated with IgG (red) or anti-IFN-c for 2 h (yellow). Error bars represent SEM for three mice. (C) Projection of different perturbation conditions
(wild-type and wild-type+IFN-c) along LV2 based on p-Mek, p-IkBa, p-Rsk, and p-Akt measured at 0.5 h post-TNF-a treatment.
doi:10.1371/journal.pbio.1001393.g007
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that this interaction was regulated by monocyte chemotactic
protein-1 (MCP-1) (Figure 8).
MCP-1 belongs to the CC chemokine group, whose members
are characterized by two adjacent cysteine residues in their N-
termini. MCP-1 is known to signal through the G protein coupled
receptor CCR2 to induce a variety of chemo-attractant functions.
CCR2 expression was initially established in monocyte and
macrophage cell lines, and hence, most studies of MCP-1 function
have focused on mononuclear cell recruitment. Nevertheless,
CCR2 is also expressed by other immune and non-immune cell
types [24–26]. As a result, MCP-1 can influence the behavior of
many different types of cells. In the intestine, MCP-1 is thought to
play a role in regulating homeostasis because it has been linked to
intestinal inflammation [27–30]. The precise mechanisms linking
MCP-1 to gut inflammation are not clear, however. In our study,
MCP-1 expression negatively correlated with the magnitude of
TNF-a-induced apoptosis in the intestinal epithelium (Figure 3C),
which was accompanied by alterations in the epithelial TNF-a
signaling network (Figure 2). Consequently, neutralization of
MCP-1 in WT animals changed both the network-wide signaling
response and the phenotypic response to TNF-a (Figure 4A,C).
These results suggested that MCP-1 plays an important role in
regulating intestinal epithelial homeostasis by altering the proximal
sensitivity of the inflammatory signaling network of epithelial cells.
Our major goal in this study was to understand how
heterologous interactions within the intestinal microenvironment
play a role in regulating the epithelial response to TNF-a. Our
initial hypothesis connecting MCP-1 to the epithelial TNF-a
response was that it is expressed by lymphocytes, and that its
presence affected epithelial sensitivity to TNF-a. Our results
painted a more complex picture, however. For example, we found
that MCP-1 was produced primarily by secretory epithelial cells
(Figure 5). It is not yet clear how adaptive lymphocytes regulate
MCP-1 expression by epithelial cells. One way for lymphocytes to
communicate with goblet and Paneth cells would be through
cytokines or chemokines. If such a mechanism were operating in
this system, we would have expected to find a signal that positively
correlated with MCP-1 in our PLSDA model, but we did not
(Figure 3C). Our failure to find a co-correlated signal likely results
from the limited scope of the cytokine analysis afforded by Bio-
Plex analysis. By extension, measurement of a larger panel of
signals may reveal the proximal regulator of MCP-1 expression by
secretory epithelial cells.
Two pieces of evidence suggested that MCP-1 indirectly
influences epithelial signaling by playing a proximal role in
regulating the identity of the immune cell complexion of the
intestinal lamina propria. First, the lack of lymphocytes in Rag1
null mice was associated with an enhanced presence of several
other immune cell types (Figure 6A), which can be construed as an
adaptation at the organismal level to the substantial perturbation
of the immune system. We also found that neutralization of MCP-
1 in WT mice broadly affected the presence of immune cell
populations in the intestine (Figure 6A). While several immune cell
types were affected, we determined experimentally that the
increased presence of plasmacytoid dendritic cells (pDCs) sensi-
tized epithelial cells to TNF-a-induced apoptosis and that MCP-1
acted upstream to regulate the number of pDCs in the intestine.
Because MCP-1 is primarily known as a chemo-attractant, the
mechanism underlying the chemo-repulsive activity of MCP-1 on
pDCs, for example whether this is direct or indirect, is still unclear.
One potentially interesting mechanism to consider is that innate
lymphoid cells (ILCs), which are not affected by the Rag1
mutation, may play a role. ILCs play an important role in
intestinal inflammation by producing pro-inflammatory cytokines,
such as IL-17 and IFN-c [31,32]. Previous studies have shown that
adaptive immune cells are important for suppressing the
inflammatory activity of innate immune cells [33,34]. Thus, the
lack of adaptive lymphocytes in Rag1 null animals is likely
associated with hyperactivity of resident ILCs. By extension, it is
possible that ILCs may be mediating the recruitment of pDCs.
Note, however, that although one population of ILC (NK cells) is
increased in Rag1 null mice, depletion of these cells did not affect
TNF-a-induced apoptosis (Figure 6B).
Unlike conventional dendritic cells, whose main function is to
sense and present antigen, pDCs are a special class of dendritic
cells that secrete cytokines. Although evidence supports the
existence of a common progenitor for both types of dendritic
Figure 8. A model for regulation of TNF-a-induced apoptosis in
the intestine. (A) Regulation of TNF-a response in the wild-type
duodenum. In this context, resident T-cells promote MCP-1 expression
by epithelial goblet cells. This MCP-1 functions to restrict pDC
recruitment to the lamina propria. In the absence of pDCs, apoptosis
induced by exogenous TNF-a is relatively low. Neutralization of MCP-1
in wild-type animals results in recruitment of pDCs and enhanced TNF-
a-induced apoptosis. (B) Regulation of TNF-a response in the Rag1 null
duodenum. The lack of intestinal T cells in Rag1 mice leads to a
reduction in MCP-1 expression by goblet cells, allowing for recruitment
of pDCs to the lamina propria. These pDCs influence the activation state
of TNF-a-induced signaling pathways in epithelial cells, ultimately
resulting in enhancement of TNF-a-induced apoptosis. Ablation of
pDCs in Rag1 null mice restores the signaling network, and therefore
the response to TNF-a, to a wild-type state. (Note, the cell surface
markers used to identify each of the relevant immune cell types is
specified.)
doi:10.1371/journal.pbio.1001393.g008
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cells, pDCs exhibit morphologies, expression profiles, and homing
properties of secretory lymphocytes [35]. pDCs also express high
levels of TLR7 and TLR9 to sense viral infections and mount type
1 interferon responses [36]. In addition to their role in infection,
pDCs are thought to play a role in autoimmune diseases, such as
lupus and psoriasis [37]. TNF-a also plays a central role in the
pathology of autoimmune disease [38]. Our signaling data
demonstrate that several TNF-a-dependent epithelial signaling
pathways were hyper-activated in the context of increased
numbers of pDCs. Surprisingly, although pDCs were associated
with enhanced TNF-a-induced apoptosis, we found that these
hyper-activated pathways were primarily known to be involved in
mitogenesis and cell survival. While it is common for cells to
induce pro-survival feedback loops following an apoptotic stimulus
[22], the effect we have characterized in the intestinal epithelium
in vivo is mostly likely due to proximal regulation of the signaling
network because apoptosis occurs at a later time point (1 h post-
TNF-a, Figure 1D) than signal activation (0.5 h post-TNF-a,
Figure S4). It is not unprecedented for pathways that normally
function to promote proliferation or survival to promote cell death
under specific circumstances, however. For example, while MAPK
signaling normally promotes proliferation, ERK is required for
cisplatin-induced apoptosis in HeLa cells [39]. We speculate that
in the intestinal epithelium, the combinatorial activation of Rsk,
Mek, Ikba, and Akt by TNF-a is interpreted as a strong pro-death
signal, even though, individually, each of these pathways promotes
survival. How do pDCs modulate the activation of these pathways
by TNF-a? Computational modeling identified interferon gamma
(IFN-c) as one of the cytokines that positively correlated with high-
magnitude apoptosis and, therefore, high numbers of pDCs
(Figure 7A). Perturbation of IFN-c in WT and Rag1 null animals
shifted both the epithelial signaling networks and the apoptotic
phenotypes (Figure 7), indicating that this cytokine functions
downstream of pDCs to potentiate TNF-a-induced apoptosis in
the intestinal epithelium. The connection between pDCs and IFN-
c was somewhat surprising, as pDCs are typically associated with
type I interferon response, which includes IFN-a [40]. Consistent
with our observations, however, pDCs have also been shown to
secrete IFN-c [41,42].
In this study, we have uncovered a novel interaction network
within the intestinal environment that controls the epithelial
response to TNF-a (Figure 8). In this network, resident adaptive
lymphocytes influence MCP-1 production by secretory epithelial
cells, which affects recruitment of IFN-c-expressing pDCs to the
lamina propria, ultimately leading to modulation of the epithelial
signaling network. Additional studies are required to determine
whether other cell types within the intestinal microenvironment,
and cytokines derived from those cell types, function within the
network. These studies demonstrate that, in the complex in vivo
environment, perturbation of a single compartment within the
network does not affect phenotypic behaviors in a univariate
manner, but instead causes systems-level shifts in multiple
components that synergistically alter outcomes.
Materials and Methods
Animals, TNF-a Time Courses, and Sample Isolation
All of the experimental animals used in this study were 8-wk-old
mice on a C57BL/6J genetic background. For TNF-a time
courses, mice were anesthetized with Avertin (tribromoethanol,
250 mg/kg in 500 ml PBS, Sigma-Aldrich), and then administered
5 or 10 mg of recombinant mouse TNF-a (Abazyme) in phosphate-
buffered saline (PBS, 50 ml total volume) by retro-orbital injection.
Mice from the same set were treated at the same time, but were
sacrificed at various time points. Control animals were anesthe-
tized, injected with PBS (50 ml) by retro-orbital injection, and then
sacrificed 2 h later.
For sample collection, animals were sacrificed and the small
intestine was removed and washed in PBS supplemented with
protease inhibitor. Duodenal and ileal tissues were lysed and
homogenized immediately in Bio-Plex lysis buffer (Bio-Rad), or
else fixed with formalin for subsequent immunohistochemical
analysis. Duodenal samples were obtained from the 1 cm of small
intestine immediately adjacent to the stomach. Ileal samples were
obtained from the 3 cm of small intestine immediately adjacent to
the cecum. All animal work performed in this study was
undertaken according to approved protocols and animal welfare
regulations as put forth by the Subcommittee on Research Animal
Care (SRAC) at the Massachusetts General Hospital.
Perturbations
For cytokine neutralization experiments, anti-MCP-1 antibody
(2 mg/kg in 50 ml PBS, R&D Systems), anti-IFN-c (2 mg/kg in
50 ml PBS, R&D Systems), or anti-MAdCAM1 (2 mg/kg in 50 ml
PBS, BD Pharmingen) was administered by retro-orbital injection
2 h prior to the TNF-a time course. Exogenous MCP-1 (2.5 mg in
50 ml PBS, Abazyme) or IFN-c (1 mg in 50 ml PBS, R&D Systems)
was administered by retro-orbital injection concurrent with TNF-
a treatment. To increase the number of secretory epithelial cells,
animals were treated daily for 5 d with DBZ (10 mmol/kg, Santa
Cruz Biotechnology) and then treated with TNF-a. DBZ was
prepared as described previously [20].
To perturb the microbiota, mice were given drinking water
supplemented with broad-spectrum antibiotics (200 mg/ml ampi-
cillin, 50 mg/ml Primaxin, Merck) for 10 d prior to the TNF-a
time course. To confirm the effect of the antibiotic, one fecal pellet
was freshly collected from each animal, homogenized in Ringer’s
solution (Fisher), and plated on Rose/MacConkey agar plates
(Hardy Diagnostics) immediately in a 1:5 dilution.
To ablate immune cells, mice were administered anti-NK1.1
(12 mg/kg, eBiosciences PK136), anti-PDCA-1 (20 mg/kg, Milte-
nyi Biotec), or clodronate liposomes (250 ml, Encapsula) for 48 h
prior to the TNF-a time course.
Immunohistochemistry and Apoptotic Measurements
Standard immunohistochemistry procedures were followed.
Slides were stained with anti-cleaved caspase 3 (Cell Signaling,
9661) with EDTA antigen retrieval. The immunohistochemistry
procedure was altered for intracellular cytokine staining for MCP-
1 such that all solutions were supplemented with 0.01% saponin
(Sigma-Aldrich). Slides were stained with anti-MCP-1 (Abcam,
ab8101, ECE.2) with citrate antigen retrieval. Apoptosis was
quantified by quantitative Western blotting analysis of cleaved
caspase 3 (CC3, Cell Signaling) in tissue lysates. Western blots
were quantified on a LI-COR Odyssey infrared imaging system.
Each measurement was normalized to CC3 values from a control
TNF-a time course (wild-type mice) loaded on the same gel.
Signaling and Cytokine Analyses
Quantitative measurements of protein phosphorylation were
collected from lysed tissue samples using Bio-Plex (Bio-Rad), a
multiplexed, bead-based system for analyzing total and phospho-
protein levels in suspension [43]. The following signals were
measured: phosphorylated inhibitor of nuclear factor B a (p-IkBa,
Ser32, and Ser36), phosphorylated c-Jun N-terminal kinase (p-Jnk,
Thr183, and Tyr185), p-Mek1 (Ser217 and Ser221), p-Erk1
(Thr202 and Tyr204) and p-Erk2 (Thr185 and Tyr187), p-Rsk
(Thr359 and Ser363), p-p38 (Thr180 and Tyr182), p-c-Jun
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(Ser63), p-Atf2 (Thr71), p-Akt (Ser473), p-S6 (Ser235 and Ser236),
phosphorylated signal transducer and activator of transduction 3
(p-Stat3, Ser727), p-Stat3 (Tyr705), and total Mek1. Tissue lysates
were quantified via BCA (bicinchoninic acid; Pierce) and equal
amounts of protein from each sample were used for the Bio-Plex
assays: 4 mg of proteins was used for assays of p-Jnk, p-Akt, p-Stat3
(Tyr705), and p-Atf2, whereas 1.5 mg of proteins was used for the
rest of the assays. These protein amounts were determined
experimentally to be within the linear ranges of activity of these
assays on small intestinal tissue samples before this analysis.
Quantitative measurements of cytokine protein levels were
collected from lysed tissue samples by Bio-Plex using Mouse
Cytokine 23-plex kit: IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6,
IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17A, eotaxin, G-
CSF, GM-CSF, IFN-c, KC, MCP-1, MIP-1a, MIP-1b,
RANTES, and TNF-a. Each Bio-Plex measurement was normal-
ized to the corresponding measurements from a control TNF-a
time course (wild-type mice) on the same plate.
Quantitative Modeling
PLSDA modeling was done as described previously [17,22,44].
Statistical models were constructed with MATLAB PLS Toolbox
6.5 (Eigenvector), with each biological replicate treated as an
individual sample so that the model could account for biological
variability. The input matrix was organized such that all time
points of the time courses for all signals were included for each
individual sample. Data were normalized by mean centering and
variance scaling. Cross-validation was performed with the
contiguous block method.
Fluorescence Activated Cell Sorting
After dissection, the 3 cm of duodenum of each mouse was
collected and washed in PBS with 0.5% BSA and 2 mM EDTA.
The intestine was weighed, homogenized mechanically, and
incubated in 0.2 mg/mL collagenase in DMEM for 1 h at 37
degrees to separate the epithelial cells, prior to single cell
suspension preparation with a cell strainer.
For FACS analysis of immune cells at a systems level, the single
cell suspensions were divided into three aliquots for staining. The
first aliquot was stained with fluorescently conjugated antibodies
for CD90.2, NK-1.1, CD11b, F4/80, Ly-6c, CD103, B220, Ly-
6G, CD49b, CD11c, and TER-119 for 1 h. The second aliquot
was stained for B220, CD11c, NK-1.1, CD11b, CD49b, and
PDCA1 for 1 h. The third aliquot was fixed with Cytofix/
Cytoperm solution (BD Biosciences) and stained for CD3, CD8,
and CD4 for 1 h, and washed and stained for Fox3p overnight. All
antibodies were obtained from BD Biosciences. Stained samples
were analyzed with a BD LSRII flow cytometer.
For experiments in which RNA was isolated from sorted cells,
the preparation of the single cell suspension was altered such that
the homogenized sample was incubated in 1 mg/mL collagenase
in DMEM for 30 min at 37 degrees. For sorting epithelial cells, the
sample was stained with an antibody for cytokeratin 20 (Acris). T
cells were sorted with CD8 or CD4, B cells with CD19 or B220,
and macrophages and dendritic cells with CD11C or F4/80.
Sorting was performed with a FACSAria III (BD) directly into
RLT buffer with b-mercaptoethanol. RNA was isolated from each
population using an RNAeasy microkit (Qiagen).
MCP-1 Expression Analysis
Real-time RT-PCR for MCP-1 was performed on the RNA
samples using standard procedures on an ABI 7900HT (Applied
Biosystems). The RNA expression level of each sample was
compared to a standard sample on the plate, and normalized using
TBP, HPRT, and GAPDH house-keeping genes to ensure the
reproducibility of the results across different cell types, with the
formula:
Relative expression~
1:9DCt(MCP-1) (standard{sample)

1:9DCt(HouseKeepingGene) (standard{sample)
The above formula represents MCP-1 mRNA expression per unit
of housekeeping gene expression. MCP-1 mRNA contribution for
each cell population was calculated by multiplying the MCP-1
expression/unit by the number of cells in each population as
determined by FACS analysis.
Supporting Information
Figure S1 Effects of lymphocyte perturbation on acute TNF-a-
induced apoptosis. (A) An example of a Western blot for caspase 3
cleavage and b-Tubulin in the duodena of Rag1 null mice (left)
and wild-type mice (right) as a time course following TNF-a (5 mg)
stimulation. (B) Caspase 3 cleavage induced 2 h post-TNF-a (5 mg)
administration within the duodena of wild-type control mice
(cyan), Rag1 null mice (red), TCRb/d (Tcrb/Tcrd) null mice (dark
red), and immunoglobulin heavy chain mu (Ighm) null mice
(brown). Data are normalized to wild-type control mice and error
bars represent SEM for three mice. (C) Quantification of CD8+ T
cells in the duodena of wild-type mice by FACS in wild-type
controls (clear) or mice pretreated with anti-MadCAM1 (2 mg/kg)
for 2 h (shaded). Treatment with anti-MadCAM1 prevents TNF-
a-induced recruitment of T cells to the intestine. Error bars
represent the SEM for three mice. (D) Caspase 3 cleavage within
the duodena of wild-type control mice (white), Rag1 null mice
(green), and wild-type mice pretreated with anti-MadCAM1
(shaded). Data are normalized to wild-type control mice and
error bars represent the SEM for three mice.
(PDF)
Figure S2 Acute TNF-a-induced apoptosis in the intestine is not
affected by modulation of the microbiota. (A) Fecal flora of wild-
type mice on normal drinking water or on drinking water
supplemented with broad spectrum antibiotics (200 mg/ml ampi-
cillin, 50 mg/ml Primaxin) for 10 d. Fecal flora were plated on
MacConkey agar (pink) and Rose agar (red). (B) Time course of
caspase 3 cleavage induced by TNF-a as determined by
quantitative Western blotting in the duodena of wild-type mice
after antibiotic treatment above (broken line) or normal drinking
water (solid line). Data are normalized to the peak signal of the
wild-type control. Error bars represent the SEM for three mice.
(PDF)
Figure S3 Signaling network sampled in our analysis. Here, we
present a manually curated network of inflammatory signaling
according to canonical pathways. We depict components and
connections that are included in our analysis (Input, TNF-a in
yellow; Signals, cytokines in light blue, phospho-proteins in dark
blue; Response, cleaved caspase 3 in red). Note that additional
connections between the nodes likely exist, and note the presence
or absence of particular connections that are cell context
dependent.
(PDF)
Figure S4 Time courses of protein phosphorylation signals
activated following exposure to TNF-a in vivo. Data points are the
means of the median fluorescent intensities resulting from the
phospho-protein assays, normalized to a loading control dataset on
each plate. The left side of each graph set contains the duodenal
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data, while the right side contains the ileal data. The color scheme
is based on genotype (cyan for wild-type, red for Rag1 null), while
the solid and broken lines represent low (5 mg) and high (10 mg)
doses of TNF-a, respectively. Error bars represent the SEM for
three mice.
(PDF)
Figure S5 Modeling signaling network shifts in modulating
TNF-a-induced apoptosis. (A) A 3-D PLSDA model describes
dosage, regional, and genotypic effects on TNF-a-induced
apoptosis. Error of classification into class 1 (late/low apoptosis,
cyan), class 2 (early/low apoptosis, blue), and class 3 (early/high
apoptosis, red) of calibration data, using models with increasing
numbers of latent variables. The average error across all classes
(black) includes the first three classes and the three ileum classes
(no apoptosis). Classification error is defined as the probability of
misclassifying a sample given the sample distribution and a model.
(B) Error of classification into classes 1, 2, and 3 of data kept out of
the cross-validation procedure, using models built with the rest of
the data, with increasing numbers of latent variables. The average
error across all classes (black) includes the first three classes and the
three ileum classes (no apoptosis). Note that the average error is
greater than the error for individual classes due to the fact that the
ileum classes (no apoptosis) are very similar at the signaling and
phenotypic level and cannot be distinguished from one another.
(C) Receiver operating characteristic (ROC) curves depicting
specificity (1-false positive rate) versus sensitivity (true positive rate)
as the numerical threshold for classification is changed. The
quality of a classification model can be evaluated by the degree by
which the curves deviate from the center diagonal, with more
deviation describing a better classification. ROC curves for the six
classes using a PLSDA with three LVs. The red circle represents
the discriminant threshold selected for a model. (D) Loadings on
LV3, the latent variable for describing the timing of apoptosis. The
y-axis quantifies the positive or negative contribution of a
particular signal to LV3. Late signals correlate to an early
apoptotic phenotype, consistent with our previous findings.
(PDF)
Figure S6 Time courses of cytokine protein expression after
administration of TNF-a in vivo. Data points are the means of the
median fluorescent intensities resulting from the cytokine assays
performed on duodenal lysates, normalized to a loading control
dataset on each plate. The color scheme is based on genotype
(cyan for wild-type, red for Rag1 null), while the solid and broken
lines represent low (5 mg) and high (10 mg) doses of TNF-a,
respectively. Error bars represent the SEM for three mice.
(PDF)
Figure S7 Statistical modeling of TNF-a-induced apoptosis in
the context of MCP-1 neutralization. (A) PLSDA model-based
prediction of the apoptotic phenotype in the duodenum based on
phospho-protein signaling data from samples derived from animals
treated with TNF-a after pretreatment with anti-MCP-1 (magen-
ta) or non-specific antibody (cyan). The y-axis is the numerical
result calculated with the PLSDA function of being classified into
the ‘‘late/low apoptosis’’ (class 1, cyan) phenotypic class. The red
broken line is the threshold that defines classification. Note that
the non-specific antibody control classified into class 1. (B) PLSDA
model-based prediction of the classification into the ‘‘early/low
apoptosis’’ (class 2, blue) phenotypic class with signaling data from
duodenal samples from animals treated with TNF-a after pre-
treatment with anti-MCP-1 (magenta) or non-specific antibody
(cyan). (C) PLSDA model-based prediction of the classification into
the ‘‘no apoptosis’’ (class 6, grey) phenotypic class with signaling
data from duodenal samples from animals treated with TNF-a
after pre-treatment with anti-MCP-1 (magenta) or non-specific
antibody (cyan).
(PDF)
Figure S8 Evaluation of exogenous MCP-1 activity and
confirmation of immune cell ablation. (A) Evaluation of MCP-1
restoration in Rag1 null animals. A single injection of 2.5 mg of
recombinant murine MCP-1 restores of intestinal level to that of
wild-type mice. (B) Effect of exogenous MCP-1 on TNF-a-induced
apoptosis in Rag1 null animals. Exogenous MCP-1 fails to protect.
(C) FACS plots demonstrating ablation of pDCs in Rag1 null
animals by treating with anti-PDCA1 (20 mg/kg) for 2 d. (D)
Validation of cell depletion experiments. Natural killer cells were
depleted by pretreating mice with anti-NK1.1 (12 mg/kg) for 2 d.
pDCs were depleted by treating mice with anti-PDCA1 (20 mg/
kg) for 2 d. Macrophages were depleted by treating animals with
clodronate liposomes (250 ml) for 2 d. In all experiments, error
bars represent the SEM for three mice.
(PDF)
Figure S9 Early TNF-a-induced signaling is modulated by
plasmacytoid dendritic cells. Early signaling (0.5 h) induced by
TNF-a in the duodenum as measured by Bio-Plex phospho-
protein signal assays for wild-type mice (cyan), wild-type mice
pretreated with anti-MCP-1 for 2 h (magenta), Rag1 null mice
(red), and Rag1 null mice pretreated with anti-PDCA-1 for 2 d
(yellow). Data are normalized to a loading control dataset on each
plate. Error bars represent the SEM for three mice.
(PDF)
Figure S10 Early cytokine induction by TNF-a is modulated by
plasmacytoid dendritic cells. Early cytokine protein levels (0.5 h)
induced by TNF-a (5 mg) in the duodenum as measured by Bio-
Plex cytokine assays for wild-type mice (cyan), wild-type mice
pretreated with anti-MCP-1 for 2 h (magenta), Rag1 null mice
(red), and Rag1 null mice pretreated with anti-PDCA-1 for 2 d
(yellow). Data are normalized to a loading control dataset on each
plate. Error bars represent the SEM for three mice.
(PDF)
Acknowledgments
We thank Nick Barker for suggesting the DBZ experiment and Andita
Nelson, Adam Chicoine, and Michael Waring for technical help with the
FACS analysis and sorting.
Author Contributions
The author(s) have made the following declarations about their
contributions: Conceived and designed the experiments: KSL MJP DAL
KMH. Performed the experiments: KSL VCR SRP. Analyzed the data:
KSL VCR MJP DAL KMH. Wrote the paper: KSL DAL KMH.
References
1. Schrofelbauer B, Hoffmann A (2011) How do pleiotropic kinase hubs me-
diate specific signaling by TNFR superfamily members? Immunol Rev 244:
29–43.
2. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis
via two sequential signaling complexes. Cell 114: 181–190.
3. Matsuzawa A, Tseng PH, Vallabhapurapu S, Luo JL, Zhang W, et al. (2008)
Essential cytoplasmic translocation of a cytokine receptor-assembled signaling
complex. Science 321: 663–668.
4. Wang L, Du F, Wang X (2008) TNF-alpha induces two distinct caspase-8
activation pathways. Cell 133: 693–703.
In Vivo Systems Analysis of TNF-Induced Apoptosis
PLOS Biology | www.plosbiology.org 13 September 2012 | Volume 10 | Issue 9 | e1001393
5. Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:
2066–2078.
6. Chaudhary R, Ghosh S (2005) Infliximab in refractory coeliac disease.
Eur J Gastroen Hepat 17: 603–604.
7. Shiotani A, Sakakibara T, Nomura M, Yamanaka Y, Nishi R, et al. (2010)
Aspirin-induced peptic ulcer and genetic polymorphisms. J Gastroen Hepatol 25
Suppl 1: S31–S34.
8. Strober W, Fuss IJ (2011) Proinflammatory cytokines in the pathogenesis of
inflammatory bowel diseases. Gastroenterology 140: 1756–1767.
9. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, et al.
(2010) Activation of beta-catenin in dendritic cells regulates immunity versus
tolerance in the intestine. Science 329: 849–853.
10. Watarai H, Sekine-Kondo E, Shigeura T, Motomura Y, Yasuda T, et al. (2012)
Development and function of invariant natural killer T cells producing T(h)2-
and T(h)17-cytokines. PLoS Biol 10: e1001255. doi:10.1371/journal.-
pbio.1001255
11. Olszak T, An D, Zeissig S, Vera MP, Richter J, et al. (2012) Microbial exposure
during early life has persistent effects on natural killer T cell function. Science
336: 489–493.
12. Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, et al. (2009) Colitis-
associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer
Cell 16: 208–219.
13. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, et al. (1995)
Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T
cells. Proc Natl Acad Sci U S A 92: 6147–6151.
14. Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Seris M, Vassalli P (1998)
Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines
(IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal.
Eur J Immunol 28: 730–744.
15. Dahan S, Rabinowitz KM,Martin AP, Berin MC,Unkeless JC, et al. (2011) Notch-
1 signaling regulates intestinal epithelial barrier function, through interaction with
CD4+ T cells, in mice and humans. Gastroenterology 140: 550–559.
16. McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, et al. (2012)
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small
intestine. Nature 483: 345–349.
17. Lau KS, Juchheim AM, Cavaliere KR, Philips SR, Lauffenburger DA, et al.
(2011) In vivo systems analysis identifies spatial and temporal aspects of the
modulation of TNF-alpha-induced apoptosis and proliferation by MAPKs. Sci
Sig 4: ra16.
18. Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, et al. (2005) In
vivo demonstration of T lymphocyte migration and amelioration of ileitis in
intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin
Exp Immunol 140: 22–31.
19. Shigematsu T, Specian RD, Wolf RE, Grisham MB, Granger DN (2001)
MAdCAM mediates lymphocyte-endothelial cell adhesion in a murine model of
chronic colitis. Am J Physiol-Gastr L 281: G1309–G1315.
20. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, et al. (2005)
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts
and adenomas into goblet cells. Nature 435: 959–963.
21. Zhang J, Patel L, Pienta KJ (2010) Targeting chemokine (C-C motif) ligand 2
(CCL2) as an example of translation of cancer molecular biology to the clinic.
Prog Mol Biol Trans Sci 95: 31–53.
22. Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, et al. (2006)
The response of human epithelial cells to TNF involves an inducible autocrine
cascade. Cell 124: 1225–1239.
23. Jorgensen C, Sherman A, Chen GI, Pasculescu A, Poliakov A, et al. (2009) Cell-
specific information processing in segregating populations of Eph receptor
Ephrin-expressing cells. Science 326: 1502–1509.
24. Christensen PJ, Du M, Moore B, Morris S, Toews GB, et al. (2004) Expression
and functional implications of CCR2 expression on murine alveolar epithelial
cells. Am J Physiol-Lung C 286: L68–L72.
25. Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, et al. (2007) CCR2 expression correlates
with prostate cancer progression. J Cell Biochem 101: 676–685.
26. Lu H, Huang D, Ransohoff RM, Zhou L (2011) Acute skeletal muscle injury:
CCL2 expression by both monocytes and injured muscle is required for repair.
FASEB J 25: 3344–3355.
27. Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL, et al. (1995)
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells
and inflammatory bowel disease mucosa. Gastroenterology 108: 40–50.
28. Mazzucchelli L, Hauser C, Zgraggen K, Wagner HE, Hess MW, et al. (1996)
Differential in situ expression of the genes encoding the chemokines MCP-1 and
RANTES in human inflammatory bowel disease. J Pathol 178: 201–206.
29. Grimm MC, Elsbury SK, Pavli P, Doe WF (1996) Enhanced expression and
production of monocyte chemoattractant protein-1 in inflammatory bowel
disease mucosa. J Leukoc Biol 59: 804–812.
30. Andres PG, Beck PL, Mizoguchi E, Mizoguchi A, Bhan AK, et al. (2000) Mice
with a selective deletion of the CC chemokine receptors 5 or 2 are protected
from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5
expression results in a NK1.1+ lymphocyte-associated Th2-type immune
response in the intestine. J Immunol 164: 6303–6312.
31. Buonocore S, Ahern PP, Uhlig HH, Ivanov, II, Littman DR, et al. (2010) Innate
lymphoid cells drive interleukin-23-dependent innate intestinal pathology.
Nature 464: 1371–1375.
32. Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, et al. (2011)
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel
disease. J Exp Med 208: 1127–1133.
33. Kim KD, Zhao J, Auh S, Yang X, Du P, et al. (2007) Adaptive immune cells
temper initial innate responses. Nat Med 13: 1248–1252.
34. Cox JH, Kljavin NM, Ota N, Leonard J, Roose-Girma M, et al. (2012)
Opposing consequences of IL-23 signaling mediated by innate and adaptive cells
in chemically induced colitis in mice. Mucosal Immunol 5: 99–109.
35. Reizis B (2010) Regulation of plasmacytoid dendritic cell development. Curr
Opin Immunol 22: 206–211.
36. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate
antiviral responses by means of TLR7-mediated recognition of single-stranded
RNA. Science 303: 1529–1531.
37. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic
acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594–606.
38. Postal M, Appenzeller S (2011) The role of Tumor Necrosis Factor-alpha (TNF-
alpha) in the pathogenesis of systemic lupus erythematosus. Cytokine 56: 537–
543.
39. Sheridan C, Brumatti G, Elgendy M, Brunet M, Martin SJ (2010) An ERK-
dependent pathway to Noxa expression regulates apoptosis by platinum-based
chemotherapeutic drugs. Oncogene 29: 6428–6441.
40. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V (2011) Plasmacytoid
dendritic cells: recent progress and open questions. Annu Rev Immunol 29: 163–
183.
41. Cox K, North M, Burke M, Singhal H, Renton S, et al. (2005) Plasmacytoid
dendritic cells (PDC) are the major DC subset innately producing cytokines in
human lymph nodes. J Leukoc Biol 78: 1142–1152.
42. Vremec D, O’Keeffe M, Hochrein H, Fuchsberger M, Caminschi I, et al. (2007)
Production of interferons by dendritic cells, plasmacytoid cells, natural killer
cells, and interferon-producing killer dendritic cells. Blood 109: 1165–1173.
43. Earley MC, Vogt RF, Jr., Shapiro HM, Mandy FF, Kellar KL, et al. (2002)
Report from a workshop on multianalyte microsphere assays. Cytometry 50:
239–242.
44. Kreeger PK, Mandhana R, Alford SK, Haigis KM, Lauffenburger DA (2009)
RAS mutations affect tumor necrosis factor-induced apoptosis in colon
carcinoma cells via ERK-modulatory negative and positive feedback circuits
along with non-ERK pathway effects. Cancer Res 69: 8191–8199.
In Vivo Systems Analysis of TNF-Induced Apoptosis
PLOS Biology | www.plosbiology.org 14 September 2012 | Volume 10 | Issue 9 | e1001393
